Papillary Thyroid Cancer and Central Lymp Node Dissection
Launched by BAŞAKŞEHIR ÇAM & SAKURA CITY HOSPITAL · May 15, 2023
Trial Information
Current as of May 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - B5 and B6 biopsy results
- Exclusion Criteria:
- • - lobectomy
About Başakşehir çam & Sakura City Hospital
Başakşehir Çam & Sakura City Hospital is a leading healthcare institution in Turkey, renowned for its state-of-the-art facilities and commitment to patient-centered care. As a prominent clinical trial sponsor, the hospital is dedicated to advancing medical research and innovation across various therapeutic areas. With a multidisciplinary team of experts and a focus on ethical practices, Başakşehir Çam & Sakura City Hospital actively collaborates with industry partners and academic institutions to facilitate cutting-edge clinical trials, aiming to improve treatment outcomes and enhance the overall quality of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported